Omalizumab to Accelerate a Symptom-driven Multi-food OIT
Omalizumab to Accelerate a Symptom-driven Multi-food OIT
Active, not recruiting · NCT04045301 · Registry updated 2024-11-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Omalizumab to Accelerate a Symptom-driven Multi-food OIT | Food IgE-mediated Allergy; Immunotherapy; Omalizumab; Physiological Effects of Drugs | Active, not recruiting | Phase 2 | 2024-11-27 | NCT04045301 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier Universitaire Sainte-Justine | Montreal | Canada | 70 |
| CIUSSS de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CHUS) | Sherbrooke | Canada | 1 |
| The Hospital For Sick Children | Toronto | Canada | 94 |